Compounding pharmacy advertising on Meta is a minefield. One wrong claim and your entire ad account is banned. If you are a compounding pharmacy and your ads were banned, the reinstatement process requires a structured approach. The good news is that compounding pharmacy accounts can be reinstated if you address the root cause.
We have managed ad accounts for compounding pharmacies across the United States. The core issue is always the same: Meta treats compounding pharmacies as healthcare advertisers and applies its strictest policies, but most compounding pharmacy ads are written without regulatory considerations.
Why Compounding Pharmacy Ads Get Banned
The biggest trigger is making claims about specific drug products or conditions. Meta scans for language implying treatment, cure, or prevention of diseases. Even saying your pharmacy specializes in hormone replacement therapy can trigger a ban if the landing page discusses specific conditions.
Other triggers include affiliate-style funnels redirecting to telehealth prescription services, ads targeting pain management or weight loss keywords, landing pages listing pricing for specific compounded medications, and missing business verification through BAV.
Regulatory Standards for Compounding Pharmacy Ads
FDA 503A is the core regulation for traditional compounding pharmacies. It allows pharmacists to prepare customized medications for individual patients. Your ads must reflect this model: you provide a service, not a product. You cannot advertise specific drug formulations as treatments.
FDA 503B covers outsourcing facilities that compound sterile products. If your pharmacy operates under 503B, your advertising must include additional disclaimers about the scale and nature of your operation.
DSHEA 1994 may apply if your compounding pharmacy also sells dietary supplements. Supplement advertising has its own restrictions around disease claims.
The BAV appeal pathway is mandatory for compounding pharmacy advertisers. Meta requires verified business documentation before allowing compounding-related ads.
Our Reinstatement Process
Audit everything. Review every active ad, every paused ad, and your entire landing page infrastructure. Identify any language that could be interpreted as a health claim, treatment promise, or product endorsement.
Remove all condition-specific language. Do not mention specific diagnoses, symptoms, or treatment outcomes. Focus on your compounding service, your pharmacy license, and your consultation process.
Complete BAV verification. Submit your pharmacy license, business registration, professional liability insurance, and domain ownership documentation. This establishes trust with Meta and prevents future bans.
Rebuild your ad creative. Use educational content that explains what compounding is and how patients can access consultations. Avoid product names, dosage information, and pricing.
Case Study: Pharmacy Account Restored
A compounding pharmacy in Florida had their ad account banned after a competitor reported their ads. The banned ads mentioned specific hormone therapy products and included pricing. We removed all product references, rewrote the ad copy to focus on compounding services and consultation availability, completed BAV verification, and submitted a comprehensive appeal. The account was reinstated in 6 days with all new ads approved.
You might also find this useful
Peptide Advertising Regulations
Ready to run these ads? Book a call at calendly.com/custodio-2/30min